Domesco Medical Import - Export Joint-Stock Corporation

HOSE:DMC Stock Report

Market Cap: ₫2.4t

Domesco Medical Import - Export Past Earnings Performance

Past criteria checks 1/6

Domesco Medical Import - Export's earnings have been declining at an average annual rate of -4.2%, while the Pharmaceuticals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 4.8% per year. Domesco Medical Import - Export's return on equity is 12%, and it has net margins of 8.3%.

Key information

-4.2%

Earnings growth rate

-4.2%

EPS growth rate

Pharmaceuticals Industry Growth13.0%
Revenue growth rate4.8%
Return on equity12.0%
Net Margin8.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Domesco Medical Import - Export makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

HOSE:DMC Revenue, expenses and earnings (VND Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,797,834149,990192,1760
30 Jun 241,794,626161,819194,6070
31 Mar 241,732,711171,856194,4880
31 Dec 231,719,032155,833188,6570
30 Sep 231,685,185173,124188,7930
30 Jun 231,639,680177,652193,1160
31 Mar 231,639,004175,596211,1820
31 Dec 221,592,727170,064218,4050
30 Sep 221,614,661158,589232,7780
30 Jun 221,603,020148,277229,5590
31 Mar 221,567,268138,996220,1330
31 Dec 211,498,395143,354215,2110
30 Sep 211,484,876134,517228,0300
30 Jun 211,427,686122,723234,6660
31 Mar 211,451,951153,518238,6330
31 Dec 201,451,954161,582235,2900
30 Sep 201,428,250181,064231,8320
30 Jun 201,471,638212,794244,2020
31 Mar 201,449,060202,017228,3290
31 Dec 191,468,390209,371225,7860
30 Sep 191,459,919210,793211,9820
30 Jun 191,419,657207,367195,9250
31 Mar 191,402,421207,269216,2160
31 Dec 181,385,088211,614225,0690
30 Sep 181,365,586197,323274,3900
30 Jun 181,368,590193,089290,4400
31 Mar 181,353,255190,740297,2490
31 Dec 171,339,651195,202294,4200
30 Sep 171,340,803189,490293,1180
30 Jun 171,310,141185,022288,3480
31 Mar 171,288,909181,457281,7620
31 Dec 161,289,294168,641291,6100
30 Sep 161,269,096167,424255,8480
30 Jun 161,277,743154,057248,6190
31 Mar 161,253,665132,782236,8280
31 Dec 151,234,031125,146225,4100
30 Sep 151,245,60694,986224,6000
30 Jun 151,260,43692,664230,1830
31 Mar 151,370,943102,389250,2990
31 Dec 141,486,060104,908262,8570
30 Sep 141,525,259127,916278,5880
30 Jun 141,562,392123,018284,0800
31 Mar 141,516,156113,457285,1420
31 Dec 131,429,609107,520278,3920

Quality Earnings: DMC has high quality earnings.

Growing Profit Margin: DMC's current net profit margins (8.3%) are lower than last year (10.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DMC's earnings have declined by 4.2% per year over the past 5 years.

Accelerating Growth: DMC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DMC had negative earnings growth (-13.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-13%).

Return on Equity

High ROE: DMC's Return on Equity (12%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 10:54
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Domesco Medical Import - Export Joint-Stock Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Khoa DoSSI Securities Corporation